Combined use of cetuximab and chemotherapy in recurrent or metastatic squamous cell carcinoma of head and neck
Author(s): XIAO Shuai
Pages: 907-909
Year: 2010 Issue: 12
Journal: Journal of International Oncology
Keyword: Antibodies; monoclonal; Head and neck neoplasms; Carcinoma; squamous cell; Drug therapy;
Abstract: 复发或转移头颈部鳞状细胞癌(SCCHN)预后较差.西妥昔单抗是一种可抑制表皮生长因子(EGFR)的单克隆抗体,并可提高包括顺铂在内的多种化疗药物疗效.多项临床研究结果显示,西妥昔单抗联合化疗对复发或转移头颈部鳞癌有效,以其高疗效和低不良反应在治疗中显示出了优势.
Pages: 907-909
Year: 2010 Issue: 12
Journal: Journal of International Oncology
Keyword: Antibodies; monoclonal; Head and neck neoplasms; Carcinoma; squamous cell; Drug therapy;
Abstract: 复发或转移头颈部鳞状细胞癌(SCCHN)预后较差.西妥昔单抗是一种可抑制表皮生长因子(EGFR)的单克隆抗体,并可提高包括顺铂在内的多种化疗药物疗效.多项临床研究结果显示,西妥昔单抗联合化疗对复发或转移头颈部鳞癌有效,以其高疗效和低不良反应在治疗中显示出了优势.
Related Articles